| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.062 | 0.3 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.3 |